Janux Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Janux Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 6% to $8,083,000. Profit margin reached -721%. Total operating expenses were $81,062,000.
Profit Margin
| 2019 | 0 | -4.23M | |
|---|---|---|---|
| 2020 | 0 | -5.25M | |
| 2021 | 3.63M | -32.55M | -895.22% |
| 2022 | 8.61M | -54.15M | -628.82% |
| 2023 | 8.08M | -58.29M | -721.18% |
JANX Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 8.08M | 8.61M | 3.63M | 0 | 0 |
Cost of revenue | 1.95M | 841K | 113K | 13K | 6K |
Gross profit | 6.12M | 7.77M | 3.52M | -13K | -6K |
Operating exp. | |||||
Research and development | 54.92M | 53.44M | 26.23M | 3.04M | 2.99M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 81.06M | 75.70M | 36.56M | 4.84M | 3.77M |
Operating income | -72.97M | -67.09M | -32.92M | -4.84M | -3.77M |
Other income (expenses), net | 14.68M | 4.03M | 257K | -1.94M | -233K |
Income before tax | -58.29M | -63.05M | -32.67M | -6.78M | -4.00M |
Income tax expense | 0 | -8.90M | -113K | -1.52M | 233K |
Net income | -58.29M | -54.15M | -32.55M | -5.25M | -4.23M |
Earnings per share | |||||
Basic EPS | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
Diluted EPS | -1.32 | -1.31 | -0.79 | -0.13 | -0.1 |
| Data source | Data source | Data source |